Dova Pharmaceuticals

Durham pharma firm Dova merging with Swedish biotech in deal worth up to $915M

Posted by WRAL TechWire | Sep 30, 2019

Dova Pharmaceuticals is being acquired by a Swedish biotech company in a deal worth as much as $915 million in a deal announced Monday.

Dova beats Street expectations under new CEO, cuts sales team by 28 positions

Posted by WRAL TechWire | Mar 7, 2019

Dova Pharmaceuticals reported fourth-quarter financial results that were better than expected, the first results under its new chief executive officer, and In January cut its sales team to 44 from 72.

Dova Pharma’s revenue, loss beats analysts’ expectations but shares drop

Posted by WRAL TechWire | Nov 12, 2018

Durham-based Dova Pharmaceuticals Inc. posted third-quarter earnings that surpassed expectations, according to a filing with the Securities and Exchange Commission. But its shares still dropped in trading on Monday.

Dova Pharma strikes marketing, sales deal with Salix

Posted by WRAL TechWire | Sep 28, 2018

Dova Pharmaceuticals Inc. announced that it entered into an exclusive agreement with Salix Pharmaceuticals to co-promote one of its products in the United States,

Big Dova Pharmaceuticals investor adds to stake in Durham firm

Posted by WRAL TechWire | Jun 11, 2018

A large investor in drug company Dova Pharmaceuticals Inc. has added to its stake in the Durham-based company, according to a securities filing.

Dova Pharmaceuticals to expand office space after FDA approval

Posted by WRAL TechWire | May 28, 2018

DURHAM — Drug company Dova Pharmaceuticals Inc. signed a deal to expand its Durham office space shortly after receiving its first U.S. Food and Drug Administration approval for one of its drugs, according to a Securities and Exchange Commission filing. Durham-based Dova signed an agreement last week to lease 21,745...

FDA approves Durham-based Dova’s drug for restoring low blood platelets

Posted by WRAL TechWire | May 22, 2018

Dova Pharmaceuticals receives FDA approval for its first commercial drug, a tablet for treating thrombocytopenia, or low blood platelet counts, which can cause dangerous bleeding.